Physician
Avila, Felipe
Avila, Felipe was paid $3.79M by Medicaid between Jan 2018 and Oct 2024, across 50 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 48% of everything it billed.
33Billing provider infoAVILA, FELIPE
WESLACO, TX 78596
WESLACO, TX 78596
33aNPI1194764225assigned 06/05/2006
33bProvider typePediatrics Physician
28Total paid$3.79M
24GClaims134,091
24DCodes billed50
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Pediatrics Physician providers in Texas
Rank by total paid#119 of 1,136
Median peer was paid$329K
This provider vs. median12×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 538 | $12K | |
| 2019 | 951 | $13K | |
| 2020 | 5,953 | $145K | |
| 2021 | 38,434 | $1.16M | |
| 2022 | 50,112 | $1.42M | |
| 2023 | 35,058 | $957K | |
| 2024incomplete | 3,045 | $83K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 48% | 51,277 | 41,706 | $1.83M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 7.4% | 3,775 | 3,733 | $281K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 7.3% | 3,332 | 3,288 | $276K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 7.2% | 3,485 | 3,450 | $274K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 7.0% | 6,756 | 6,019 | $267K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 5.3% | 15,088 | 6,796 | $203K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.9% | 2,548 | 2,517 | $186K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.1% | 3,144 | 2,925 | $157K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.4% | 5,558 | 2,650 | $53K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.1% | 3,012 | 2,876 | $40K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 452 | 446 | $38K |
| 99000 | <1% | 2,861 | 2,725 | $30K |
38 more codes
| 99381 | <1% | 348 | $28K | |
| 80053 | Comprehensive metabolic panel | <1% | 2,812 | $24K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,929 | $19K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 2,057 | $16K |
| 87807 | <1% | 1,157 | $12K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 201 | $12K |
| 90461 | <1% | 1,040 | $11K | |
| G0270 | Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes | <1% | 6,829 | $9K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 454 | $6K |
| 96161 | <1% | 2,181 | $5K | |
| 92587 | <1% | 240 | $4K | |
| 81003 | <1% | 1,515 | $3K | |
| 86308 | <1% | 552 | $2K | |
| 94010 | <1% | 82 | $2K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 57 | $2K |
| 90474 | <1% | 132 | $1K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 42 | $981.60 |
| 97170 | <1% | 58 | $550.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 28 | $386.37 |
| 86580 | <1% | 30 | $219.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 12 | $142.80 |
| 94760 | <1% | 78 | $141.36 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 6,814 | $30.00 |
| 90686 | <1% | 703 | $18.96 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 28 | $1.20 |
| 90716 | 0% | 28 | $0.00 | |
| 90696 | 0% | 41 | $0.00 | |
| 90651 | 0% | 29 | $0.00 | |
| 90680 | 0% | 209 | $0.00 | |
| 90723 | 0% | 355 | $0.00 | |
| 90648 | 0% | 573 | $0.00 | |
| 90633 | 0% | 144 | $0.00 | |
| 90734 | 0% | 207 | $0.00 | |
| 90715 | 0% | 60 | $0.00 | |
| 90670 | 0% | 640 | $0.00 | |
| 90710 | 0% | 104 | $0.00 | |
| 90658 | 0% | 15 | $0.00 | |
| 90707 | 0% | 19 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.